Home › Germ Cell and Embryonal Cancer › Massachusetts › Boston
Germ Cell and Embryonal Cancer clinical trials in Boston, MA
3 studies for Germ Cell and Embryonal Cancer are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
RecruitingPhase 3
- Dana-Farber/Harvard Cancer Center, Boston
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RecruitingPhase 3
- Tufts Medical Center, Boston
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- Massachusetts General Hospital,, Boston
Germ Cell and Embryonal Cancer trials in other cities
- Houston, TX6 studies
- Columbus, OH5 studies
- New York City, NY5 studies
- St. Louis, MO4 studies
- Chicago, IL4 studies
- Indianapolis, IN4 studies
- Memphis, TN3 studies
- Dallas, TX3 studies
- Winston-Salem, NC3 studies
- Greenburgh, NY3 studies
- San Francisco, CA3 studies
- Clifton, NJ3 studies
Other studies in Boston
- Breast Cancer112 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)85 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.